跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA GRINDEKS 25 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA GRINDEKS 25 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA GRINDEKS 25 MG CAPSULAS DURAS EFG
Grindeks As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 17, 2021
Approval ID
506d80e732dffa2e
Company
Grindeks As
Type
Standard
Approval Details
Approval Id
506d80e732dffa2e
Drug Cima Aemps Name
LENALIDOMIDA GRINDEKS 25 MG CAPSULAS DURAS EFG
Register Number
86080
Holder Company Name
Grindeks As
Marketing Company Name
Grindeks Kalceks Espana S.L.
Holder Company Detail Path
/organization/grindeks-as
Authorization Date
2021-09-17
Dosage Form
CÁPSULA DURA
Dose
25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Grindeks As
Company Detail Path
/organization/grindeks-as
Company Information
Pharmaceutical Company Name
Grindeks AS
Country Name
Latvia
Website
http://grindeks.eu
Active Ingredients
CLORURO AMONICO DE LENALIDOMIDA
30,16 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 17, 2021
Approval ID
506d80e732dffa2e
Type
Standard
Back to CIMA-AEMPS Approvals
